JPH04271784A - 5-substituted hydantoin racemase and gene capable of coding the same - Google Patents
5-substituted hydantoin racemase and gene capable of coding the sameInfo
- Publication number
- JPH04271784A JPH04271784A JP3065591A JP6559191A JPH04271784A JP H04271784 A JPH04271784 A JP H04271784A JP 3065591 A JP3065591 A JP 3065591A JP 6559191 A JP6559191 A JP 6559191A JP H04271784 A JPH04271784 A JP H04271784A
- Authority
- JP
- Japan
- Prior art keywords
- plasmid
- substituted hydantoin
- enzyme
- gene
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010088443 hydantoin racemase Proteins 0.000 title claims abstract description 14
- 108090000623 proteins and genes Proteins 0.000 title abstract description 14
- 150000001413 amino acids Chemical class 0.000 claims abstract description 13
- 239000013612 plasmid Substances 0.000 abstract description 46
- 150000001469 hydantoins Chemical class 0.000 abstract description 26
- 102000004190 Enzymes Human genes 0.000 abstract description 23
- 108090000790 Enzymes Proteins 0.000 abstract description 23
- 229940091173 hydantoin Drugs 0.000 abstract description 22
- 108091008146 restriction endonucleases Proteins 0.000 abstract description 20
- 241000588724 Escherichia coli Species 0.000 abstract description 17
- 244000005700 microbiome Species 0.000 abstract description 9
- 239000013598 vector Substances 0.000 abstract description 8
- 241000589516 Pseudomonas Species 0.000 abstract description 2
- 230000009466 transformation Effects 0.000 abstract 2
- 239000001963 growth medium Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 18
- 230000006340 racemization Effects 0.000 description 17
- 229940024606 amino acid Drugs 0.000 description 14
- 235000001014 amino acid Nutrition 0.000 description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 101710087110 ORF6 protein Proteins 0.000 description 9
- 101710095001 Uncharacterized protein in nifU 5'region Proteins 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- -1 2-methylthioethyl group Chemical group 0.000 description 8
- 229960004452 methionine Drugs 0.000 description 8
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 8
- SBKRXUMXMKBCLD-SCSAIBSYSA-N (R)-5-[2-(methylthio)ethyl]hydantoin Chemical compound CSCC[C@H]1NC(=O)NC1=O SBKRXUMXMKBCLD-SCSAIBSYSA-N 0.000 description 7
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 7
- COYHRQWNJDJCNA-NUJDXYNKSA-N Thr-Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O COYHRQWNJDJCNA-NUJDXYNKSA-N 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 6
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 101710159752 Poly(3-hydroxyalkanoate) polymerase subunit PhaE Proteins 0.000 description 5
- 101710130262 Probable Vpr-like protein Proteins 0.000 description 5
- 229930182817 methionine Natural products 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- 101000768957 Acholeplasma phage L2 Uncharacterized 37.2 kDa protein Proteins 0.000 description 4
- 101000823746 Acidianus ambivalens Uncharacterized 17.7 kDa protein in bps2 3'region Proteins 0.000 description 4
- 101000916369 Acidianus ambivalens Uncharacterized protein in sor 5'region Proteins 0.000 description 4
- 101000769342 Acinetobacter guillouiae Uncharacterized protein in rpoN-murA intergenic region Proteins 0.000 description 4
- 101000823696 Actinobacillus pleuropneumoniae Uncharacterized glycosyltransferase in aroQ 3'region Proteins 0.000 description 4
- 101000786513 Agrobacterium tumefaciens (strain 15955) Uncharacterized protein outside the virF region Proteins 0.000 description 4
- 101000618005 Alkalihalobacillus pseudofirmus (strain ATCC BAA-2126 / JCM 17055 / OF4) Uncharacterized protein BpOF4_00885 Proteins 0.000 description 4
- 102100020724 Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Human genes 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 101000967489 Azorhizobium caulinodans (strain ATCC 43989 / DSM 5975 / JCM 20966 / LMG 6465 / NBRC 14845 / NCIMB 13405 / ORS 571) Uncharacterized protein AZC_3924 Proteins 0.000 description 4
- 101000823761 Bacillus licheniformis Uncharacterized 9.4 kDa protein in flaL 3'region Proteins 0.000 description 4
- 101000819719 Bacillus methanolicus Uncharacterized N-acetyltransferase in lysA 3'region Proteins 0.000 description 4
- 101000789586 Bacillus subtilis (strain 168) UPF0702 transmembrane protein YkjA Proteins 0.000 description 4
- 101000792624 Bacillus subtilis (strain 168) Uncharacterized protein YbxH Proteins 0.000 description 4
- 101000790792 Bacillus subtilis (strain 168) Uncharacterized protein YckC Proteins 0.000 description 4
- 101000819705 Bacillus subtilis (strain 168) Uncharacterized protein YlxR Proteins 0.000 description 4
- 101000948218 Bacillus subtilis (strain 168) Uncharacterized protein YtxJ Proteins 0.000 description 4
- 101000718627 Bacillus thuringiensis subsp. kurstaki Putative RNA polymerase sigma-G factor Proteins 0.000 description 4
- 101000641200 Bombyx mori densovirus Putative non-structural protein Proteins 0.000 description 4
- 101000947633 Claviceps purpurea Uncharacterized 13.8 kDa protein Proteins 0.000 description 4
- 102100031725 Cortactin-binding protein 2 Human genes 0.000 description 4
- 101000948901 Enterobacteria phage T4 Uncharacterized 16.0 kDa protein in segB-ipI intergenic region Proteins 0.000 description 4
- 101000805958 Equine herpesvirus 4 (strain 1942) Virion protein US10 homolog Proteins 0.000 description 4
- 101000790442 Escherichia coli Insertion element IS2 uncharacterized 11.1 kDa protein Proteins 0.000 description 4
- 101000788354 Escherichia phage P2 Uncharacterized 8.2 kDa protein in gpA 5'region Proteins 0.000 description 4
- 101000770304 Frankia alni UPF0460 protein in nifX-nifW intergenic region Proteins 0.000 description 4
- 101000797344 Geobacillus stearothermophilus Putative tRNA (cytidine(34)-2'-O)-methyltransferase Proteins 0.000 description 4
- 101000748410 Geobacillus stearothermophilus Uncharacterized protein in fumA 3'region Proteins 0.000 description 4
- 101000772675 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) UPF0438 protein HI_0847 Proteins 0.000 description 4
- 101000631019 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) Uncharacterized protein HI_0350 Proteins 0.000 description 4
- 101000768938 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 8.9 kDa protein in int-C1 intergenic region Proteins 0.000 description 4
- 101000785414 Homo sapiens Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Proteins 0.000 description 4
- 101000782488 Junonia coenia densovirus (isolate pBRJ/1990) Putative non-structural protein NS2 Proteins 0.000 description 4
- 101000811523 Klebsiella pneumoniae Uncharacterized 55.8 kDa protein in cps region Proteins 0.000 description 4
- 101000818409 Lactococcus lactis subsp. lactis Uncharacterized HTH-type transcriptional regulator in lacX 3'region Proteins 0.000 description 4
- 101000878851 Leptolyngbya boryana Putative Fe(2+) transport protein A Proteins 0.000 description 4
- 101000758828 Methanosarcina barkeri (strain Fusaro / DSM 804) Uncharacterized protein Mbar_A1602 Proteins 0.000 description 4
- 101001122401 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF3 Proteins 0.000 description 4
- 101001055788 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) Pentapeptide repeat protein MfpA Proteins 0.000 description 4
- 108700026244 Open Reading Frames Proteins 0.000 description 4
- 101000740670 Orgyia pseudotsugata multicapsid polyhedrosis virus Protein C42 Proteins 0.000 description 4
- 101000769182 Photorhabdus luminescens Uncharacterized protein in pnp 3'region Proteins 0.000 description 4
- 101710197985 Probable protein Rev Proteins 0.000 description 4
- 101000961392 Pseudescherichia vulneris Uncharacterized 29.9 kDa protein in crtE 3'region Proteins 0.000 description 4
- 101000731030 Pseudomonas oleovorans Poly(3-hydroxyalkanoate) polymerase 2 Proteins 0.000 description 4
- 101001065485 Pseudomonas putida Probable fatty acid methyltransferase Proteins 0.000 description 4
- 101000711023 Rhizobium leguminosarum bv. trifolii Uncharacterized protein in tfuA 3'region Proteins 0.000 description 4
- 101000948156 Rhodococcus erythropolis Uncharacterized 47.3 kDa protein in thcA 5'region Proteins 0.000 description 4
- 101000917565 Rhodococcus fascians Uncharacterized 33.6 kDa protein in fasciation locus Proteins 0.000 description 4
- 101000790284 Saimiriine herpesvirus 2 (strain 488) Uncharacterized 9.5 kDa protein in DHFR 3'region Proteins 0.000 description 4
- 101000936719 Streptococcus gordonii Accessory Sec system protein Asp3 Proteins 0.000 description 4
- 101000788499 Streptomyces coelicolor Uncharacterized oxidoreductase in mprA 5'region Proteins 0.000 description 4
- 101001102841 Streptomyces griseus Purine nucleoside phosphorylase ORF3 Proteins 0.000 description 4
- 101000708557 Streptomyces lincolnensis Uncharacterized 17.2 kDa protein in melC2-rnhH intergenic region Proteins 0.000 description 4
- 101000649826 Thermotoga neapolitana Putative anti-sigma factor antagonist TM1081 homolog Proteins 0.000 description 4
- 101000827562 Vibrio alginolyticus Uncharacterized protein in proC 3'region Proteins 0.000 description 4
- 101000778915 Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) Uncharacterized membrane protein VP2115 Proteins 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 101000621943 Acholeplasma phage L2 Probable integrase/recombinase Proteins 0.000 description 3
- 101000618348 Allochromatium vinosum (strain ATCC 17899 / DSM 180 / NBRC 103801 / NCIMB 10441 / D) Uncharacterized protein Alvin_0065 Proteins 0.000 description 3
- 101000781117 Autographa californica nuclear polyhedrosis virus Uncharacterized 12.4 kDa protein in CTL-LEF2 intergenic region Proteins 0.000 description 3
- 101000708323 Azospirillum brasilense Uncharacterized 28.8 kDa protein in nifR3-like 5'region Proteins 0.000 description 3
- 101000770311 Azotobacter chroococcum mcd 1 Uncharacterized 19.8 kDa protein in nifW 5'region Proteins 0.000 description 3
- 101000748761 Bacillus subtilis (strain 168) Uncharacterized MFS-type transporter YcxA Proteins 0.000 description 3
- 101000765620 Bacillus subtilis (strain 168) Uncharacterized protein YlxP Proteins 0.000 description 3
- 101000916134 Bacillus subtilis (strain 168) Uncharacterized protein YqxJ Proteins 0.000 description 3
- 101000754349 Bordetella pertussis (strain Tohama I / ATCC BAA-589 / NCTC 13251) UPF0065 protein BP0148 Proteins 0.000 description 3
- 101000827633 Caldicellulosiruptor sp. (strain Rt8B.4) Uncharacterized 23.9 kDa protein in xynA 3'region Proteins 0.000 description 3
- 101000947628 Claviceps purpurea Uncharacterized 11.8 kDa protein Proteins 0.000 description 3
- 101000686796 Clostridium perfringens Replication protein Proteins 0.000 description 3
- 101000788129 Escherichia coli Uncharacterized protein in sul1 3'region Proteins 0.000 description 3
- 101000788370 Escherichia phage P2 Uncharacterized 12.9 kDa protein in GpA 3'region Proteins 0.000 description 3
- 101000787096 Geobacillus stearothermophilus Uncharacterized protein in gldA 3'region Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 101000976889 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 19.2 kDa protein in cox-rep intergenic region Proteins 0.000 description 3
- 101000827627 Klebsiella pneumoniae Putative low molecular weight protein-tyrosine-phosphatase Proteins 0.000 description 3
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 3
- 229930195722 L-methionine Natural products 0.000 description 3
- 101001130841 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF5 Proteins 0.000 description 3
- DEWDMTSMCKXBNP-SCSAIBSYSA-N N-carbamoyl-D-methionine Chemical compound CSCC[C@H](C(O)=O)NC(N)=O DEWDMTSMCKXBNP-SCSAIBSYSA-N 0.000 description 3
- 241001148197 Pseudomonas sp. NS671 Species 0.000 description 3
- 108020004511 Recombinant DNA Proteins 0.000 description 3
- 101000974028 Rhizobium leguminosarum bv. viciae (strain 3841) Putative cystathionine beta-lyase Proteins 0.000 description 3
- 101000756519 Rhodobacter capsulatus (strain ATCC BAA-309 / NBRC 16581 / SB1003) Uncharacterized protein RCAP_rcc00048 Proteins 0.000 description 3
- 101000948219 Rhodococcus erythropolis Uncharacterized 11.5 kDa protein in thcD 3'region Proteins 0.000 description 3
- 101000936711 Streptococcus gordonii Accessory secretory protein Asp4 Proteins 0.000 description 3
- 101000929863 Streptomyces cinnamonensis Monensin polyketide synthase putative ketoacyl reductase Proteins 0.000 description 3
- 101000788468 Streptomyces coelicolor Uncharacterized protein in mprR 3'region Proteins 0.000 description 3
- 101000845085 Streptomyces violaceoruber Granaticin polyketide synthase putative ketoacyl reductase 1 Proteins 0.000 description 3
- 101000711771 Thiocystis violacea Uncharacterized 76.5 kDa protein in phbC 3'region Proteins 0.000 description 3
- 101000711318 Vibrio alginolyticus Uncharacterized 11.6 kDa protein in scrR 3'region Proteins 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 108091022884 dihydropyrimidinase Proteins 0.000 description 3
- 238000001641 gel filtration chromatography Methods 0.000 description 3
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- DEWDMTSMCKXBNP-UHFFFAOYSA-N 2-(carbamoylamino)-4-methylsulfanylbutanoic acid Chemical compound CSCCC(C(O)=O)NC(N)=O DEWDMTSMCKXBNP-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 102100036238 Dihydropyrimidinase Human genes 0.000 description 2
- 108090000604 Hydrolases Proteins 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 108010005233 alanylglutamic acid Proteins 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 238000005185 salting out Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- JTTHKOPSMAVJFE-SECBINFHSA-N (2r)-2-azaniumyl-4-phenylbutanoate Chemical compound [O-]C(=O)[C@H]([NH3+])CCC1=CC=CC=C1 JTTHKOPSMAVJFE-SECBINFHSA-N 0.000 description 1
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 description 1
- UUFQTNFCRMXOAE-UHFFFAOYSA-N 1-methylmethylene Chemical compound C[CH] UUFQTNFCRMXOAE-UHFFFAOYSA-N 0.000 description 1
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 1
- 125000003143 4-hydroxybenzyl group Chemical group [H]C([*])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 description 1
- SBKRXUMXMKBCLD-UHFFFAOYSA-N 5-(2-methylsulfanylethyl)imidazolidine-2,4-dione Chemical compound CSCCC1NC(=O)NC1=O SBKRXUMXMKBCLD-UHFFFAOYSA-N 0.000 description 1
- 239000005541 ACE inhibitor Substances 0.000 description 1
- HHGYNJRJIINWAK-FXQIFTODSA-N Ala-Ala-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N HHGYNJRJIINWAK-FXQIFTODSA-N 0.000 description 1
- SVBXIUDNTRTKHE-CIUDSAMLSA-N Ala-Arg-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O SVBXIUDNTRTKHE-CIUDSAMLSA-N 0.000 description 1
- PUBLUECXJRHTBK-ACZMJKKPSA-N Ala-Glu-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O PUBLUECXJRHTBK-ACZMJKKPSA-N 0.000 description 1
- XYTNPQNAZREREP-XQXXSGGOSA-N Ala-Glu-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XYTNPQNAZREREP-XQXXSGGOSA-N 0.000 description 1
- CXISPYVYMQWFLE-VKHMYHEASA-N Ala-Gly Chemical compound C[C@H]([NH3+])C(=O)NCC([O-])=O CXISPYVYMQWFLE-VKHMYHEASA-N 0.000 description 1
- CWEAKSWWKHGTRJ-BQBZGAKWSA-N Ala-Gly-Met Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O CWEAKSWWKHGTRJ-BQBZGAKWSA-N 0.000 description 1
- GFEDXKNBZMPEDM-KZVJFYERSA-N Ala-Met-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GFEDXKNBZMPEDM-KZVJFYERSA-N 0.000 description 1
- YJHKTAMKPGFJCT-NRPADANISA-N Ala-Val-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O YJHKTAMKPGFJCT-NRPADANISA-N 0.000 description 1
- REWSWYIDQIELBE-FXQIFTODSA-N Ala-Val-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O REWSWYIDQIELBE-FXQIFTODSA-N 0.000 description 1
- 101710129690 Angiotensin-converting enzyme inhibitor Proteins 0.000 description 1
- VDBKFYYIBLXEIF-GUBZILKMSA-N Arg-Gln-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O VDBKFYYIBLXEIF-GUBZILKMSA-N 0.000 description 1
- 241000186063 Arthrobacter Species 0.000 description 1
- OLISTMZJGQUOGS-GMOBBJLQSA-N Asn-Ile-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N OLISTMZJGQUOGS-GMOBBJLQSA-N 0.000 description 1
- JTXVXGXTRXMOFJ-FXQIFTODSA-N Asn-Pro-Asn Chemical compound NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O JTXVXGXTRXMOFJ-FXQIFTODSA-N 0.000 description 1
- YNQIDCRRTWGHJD-ZLUOBGJFSA-N Asp-Asn-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(O)=O YNQIDCRRTWGHJD-ZLUOBGJFSA-N 0.000 description 1
- HICVMZCGVFKTPM-BQBZGAKWSA-N Asp-Pro-Gly Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O HICVMZCGVFKTPM-BQBZGAKWSA-N 0.000 description 1
- QSFHZPQUAAQHAQ-CIUDSAMLSA-N Asp-Ser-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O QSFHZPQUAAQHAQ-CIUDSAMLSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 101710086378 Bradykinin-potentiating and C-type natriuretic peptides Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 101150065749 Churc1 gene Proteins 0.000 description 1
- 241000766026 Coregonus nasus Species 0.000 description 1
- BUAUGQJXGNRTQE-AAEUAGOBSA-N Cys-Trp-Gly Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CS)N BUAUGQJXGNRTQE-AAEUAGOBSA-N 0.000 description 1
- LJCWONGJFPCTTL-SSDOTTSWSA-N D-4-hydroxyphenylglycine Chemical compound [O-]C(=O)[C@H]([NH3+])C1=CC=C(O)C=C1 LJCWONGJFPCTTL-SSDOTTSWSA-N 0.000 description 1
- XUJNEKJLAYXESH-UWTATZPHSA-N D-Cysteine Chemical compound SC[C@@H](N)C(O)=O XUJNEKJLAYXESH-UWTATZPHSA-N 0.000 description 1
- ZGUNAGUHMKGQNY-SSDOTTSWSA-N D-alpha-phenylglycine Chemical compound OC(=O)[C@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-SSDOTTSWSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 229930195710 D‐cysteine Natural products 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- FFVXLVGUJBCKRX-UKJIMTQDSA-N Gln-Ile-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CCC(=O)N)N FFVXLVGUJBCKRX-UKJIMTQDSA-N 0.000 description 1
- GURIQZQSTBBHRV-SRVKXCTJSA-N Gln-Lys-Arg Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GURIQZQSTBBHRV-SRVKXCTJSA-N 0.000 description 1
- STHSGOZLFLFGSS-SUSMZKCASA-N Gln-Thr-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O STHSGOZLFLFGSS-SUSMZKCASA-N 0.000 description 1
- RLZBLVSJDFHDBL-KBIXCLLPSA-N Glu-Ala-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O RLZBLVSJDFHDBL-KBIXCLLPSA-N 0.000 description 1
- SBYVDRJAXWSXQL-AVGNSLFASA-N Glu-Asn-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SBYVDRJAXWSXQL-AVGNSLFASA-N 0.000 description 1
- JVSBYEDSSRZQGV-GUBZILKMSA-N Glu-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCC(O)=O JVSBYEDSSRZQGV-GUBZILKMSA-N 0.000 description 1
- AUTNXSQEVVHSJK-YVNDNENWSA-N Glu-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O AUTNXSQEVVHSJK-YVNDNENWSA-N 0.000 description 1
- HRBYTAIBKPNZKQ-AVGNSLFASA-N Glu-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(O)=O HRBYTAIBKPNZKQ-AVGNSLFASA-N 0.000 description 1
- CBEUFCJRFNZMCU-SRVKXCTJSA-N Glu-Met-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O CBEUFCJRFNZMCU-SRVKXCTJSA-N 0.000 description 1
- UUTGYDAKPISJAO-JYJNAYRXSA-N Glu-Tyr-Leu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 UUTGYDAKPISJAO-JYJNAYRXSA-N 0.000 description 1
- VSVZIEVNUYDAFR-YUMQZZPRSA-N Gly-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN VSVZIEVNUYDAFR-YUMQZZPRSA-N 0.000 description 1
- XUDLUKYPXQDCRX-BQBZGAKWSA-N Gly-Arg-Asn Chemical compound [H]NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O XUDLUKYPXQDCRX-BQBZGAKWSA-N 0.000 description 1
- HKSNHPVETYYJBK-LAEOZQHASA-N Gly-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)CN HKSNHPVETYYJBK-LAEOZQHASA-N 0.000 description 1
- CLNSYANKYVMZNM-UWVGGRQHSA-N Gly-Lys-Arg Chemical compound NCCCC[C@H](NC(=O)CN)C(=O)N[C@H](C(O)=O)CCCN=C(N)N CLNSYANKYVMZNM-UWVGGRQHSA-N 0.000 description 1
- BIAKMWKJMQLZOJ-ZKWXMUAHSA-N His-Ala-Ala Chemical compound C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(O)=O BIAKMWKJMQLZOJ-ZKWXMUAHSA-N 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- SPQWWEZBHXHUJN-KBIXCLLPSA-N Ile-Glu-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O SPQWWEZBHXHUJN-KBIXCLLPSA-N 0.000 description 1
- CKRFDMPBSWYOBT-PPCPHDFISA-N Ile-Lys-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N CKRFDMPBSWYOBT-PPCPHDFISA-N 0.000 description 1
- BCISUQVFDGYZBO-QSFUFRPTSA-N Ile-Val-Asp Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(O)=O BCISUQVFDGYZBO-QSFUFRPTSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241000880493 Leptailurus serval Species 0.000 description 1
- BQSLGJHIAGOZCD-CIUDSAMLSA-N Leu-Ala-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O BQSLGJHIAGOZCD-CIUDSAMLSA-N 0.000 description 1
- JQSXWJXBASFONF-KKUMJFAQSA-N Leu-Asp-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JQSXWJXBASFONF-KKUMJFAQSA-N 0.000 description 1
- APFJUBGRZGMQFF-QWRGUYRKSA-N Leu-Gly-Lys Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN APFJUBGRZGMQFF-QWRGUYRKSA-N 0.000 description 1
- POZULHZYLPGXMR-ONGXEEELSA-N Leu-Gly-Val Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O POZULHZYLPGXMR-ONGXEEELSA-N 0.000 description 1
- PBGDOSARRIJMEV-DLOVCJGASA-N Leu-His-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(O)=O PBGDOSARRIJMEV-DLOVCJGASA-N 0.000 description 1
- YOKVEHGYYQEQOP-QWRGUYRKSA-N Leu-Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YOKVEHGYYQEQOP-QWRGUYRKSA-N 0.000 description 1
- QMKFDEUJGYNFMC-AVGNSLFASA-N Leu-Pro-Arg Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O QMKFDEUJGYNFMC-AVGNSLFASA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- LCMWVZLBCUVDAZ-IUCAKERBSA-N Lys-Gly-Glu Chemical compound [NH3+]CCCC[C@H]([NH3+])C(=O)NCC(=O)N[C@H](C([O-])=O)CCC([O-])=O LCMWVZLBCUVDAZ-IUCAKERBSA-N 0.000 description 1
- HKXSZKJMDBHOTG-CIUDSAMLSA-N Lys-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN HKXSZKJMDBHOTG-CIUDSAMLSA-N 0.000 description 1
- YFQSSOAGMZGXFT-MEYUZBJRSA-N Lys-Thr-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O YFQSSOAGMZGXFT-MEYUZBJRSA-N 0.000 description 1
- RPWQJSBMXJSCPD-XUXIUFHCSA-N Lys-Val-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(O)=O RPWQJSBMXJSCPD-XUXIUFHCSA-N 0.000 description 1
- HOZNVKDCKZPRER-XUXIUFHCSA-N Met-Lys-Ile Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HOZNVKDCKZPRER-XUXIUFHCSA-N 0.000 description 1
- 101500006448 Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) Endonuclease PI-MboI Proteins 0.000 description 1
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
- 101000764567 Nephroselmis olivacea Photosystem I assembly protein Ycf4 Proteins 0.000 description 1
- 101150007210 ORF6 gene Proteins 0.000 description 1
- MVIJMIZJPHQGEN-IHRRRGAJSA-N Phe-Ser-Val Chemical compound CC(C)[C@@H](C([O-])=O)NC(=O)[C@H](CO)NC(=O)[C@@H]([NH3+])CC1=CC=CC=C1 MVIJMIZJPHQGEN-IHRRRGAJSA-N 0.000 description 1
- BQMFWUKNOCJDNV-HJWJTTGWSA-N Phe-Val-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BQMFWUKNOCJDNV-HJWJTTGWSA-N 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- FELJDCNGZFDUNR-WDSKDSINSA-N Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 FELJDCNGZFDUNR-WDSKDSINSA-N 0.000 description 1
- PUQRDHNIOONJJN-AVGNSLFASA-N Pro-Lys-Met Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(O)=O PUQRDHNIOONJJN-AVGNSLFASA-N 0.000 description 1
- OQSGBXGNAFQGGS-CYDGBPFRSA-N Pro-Val-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O OQSGBXGNAFQGGS-CYDGBPFRSA-N 0.000 description 1
- FHJQROWZEJFZPO-SRVKXCTJSA-N Pro-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 FHJQROWZEJFZPO-SRVKXCTJSA-N 0.000 description 1
- 102100038239 Protein Churchill Human genes 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- 101001009851 Rattus norvegicus Guanylate cyclase 2G Proteins 0.000 description 1
- BTPAWKABYQMKKN-LKXGYXEUSA-N Ser-Asp-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BTPAWKABYQMKKN-LKXGYXEUSA-N 0.000 description 1
- MOINZPRHJGTCHZ-MMWGEVLESA-N Ser-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N MOINZPRHJGTCHZ-MMWGEVLESA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 101100073357 Streptomyces halstedii sch2 gene Proteins 0.000 description 1
- IQPWNQRRAJHOKV-KATARQTJSA-N Thr-Ser-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN IQPWNQRRAJHOKV-KATARQTJSA-N 0.000 description 1
- ZESGVALRVJIVLZ-VFCFLDTKSA-N Thr-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@@H]1C(=O)O)N)O ZESGVALRVJIVLZ-VFCFLDTKSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- OLWFDNLLBWQWCP-STQMWFEESA-N Tyr-Gly-Met Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O OLWFDNLLBWQWCP-STQMWFEESA-N 0.000 description 1
- OJCISMMNNUNNJA-BZSNNMDCSA-N Tyr-Tyr-Asp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(O)=O)C(O)=O)C1=CC=C(O)C=C1 OJCISMMNNUNNJA-BZSNNMDCSA-N 0.000 description 1
- ASQFIHTXXMFENG-XPUUQOCRSA-N Val-Ala-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O ASQFIHTXXMFENG-XPUUQOCRSA-N 0.000 description 1
- ISERLACIZUGCDX-ZKWXMUAHSA-N Val-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N ISERLACIZUGCDX-ZKWXMUAHSA-N 0.000 description 1
- YODDULVCGFQRFZ-ZKWXMUAHSA-N Val-Asp-Ser Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O YODDULVCGFQRFZ-ZKWXMUAHSA-N 0.000 description 1
- HPANGHISDXDUQY-ULQDDVLXSA-N Val-Lys-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N HPANGHISDXDUQY-ULQDDVLXSA-N 0.000 description 1
- GBIUHAYJGWVNLN-UHFFFAOYSA-N Val-Ser-Pro Natural products CC(C)C(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O GBIUHAYJGWVNLN-UHFFFAOYSA-N 0.000 description 1
- DLRZGNXCXUGIDG-KKHAAJSZSA-N Val-Thr-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N)O DLRZGNXCXUGIDG-KKHAAJSZSA-N 0.000 description 1
- HTONZBWRYUKUKC-RCWTZXSCSA-N Val-Thr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HTONZBWRYUKUKC-RCWTZXSCSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 108010011559 alanylphenylalanine Proteins 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 108010057083 glutamyl-aspartyl-leucine Proteins 0.000 description 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
- 108010000434 glycyl-alanyl-leucine Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 238000006912 hydrolase reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 125000006301 indolyl methyl group Chemical group 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 108010005942 methionylglycine Proteins 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108010029020 prolylglycine Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 108010071207 serylmethionine Proteins 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 108010072986 threonyl-seryl-lysine Proteins 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 108010051110 tyrosyl-lysine Proteins 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000002132 β-lactam antibiotic Substances 0.000 description 1
- 229940124586 β-lactam antibiotics Drugs 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は5−置換ヒダントインを
ラセミ化する方法に関する。FIELD OF THE INVENTION This invention relates to a process for racemizing 5-substituted hydantoins.
【0002】0002
【従来の技術】DL−5−置換ヒダントインを相当する
光学活性アミノ酸に変換する微生物として、フラボバク
テリウム属(特公昭61−12296)、バチルス属(
特公昭63−24895)、シュードモナス属(特公昭
64−71476)、アースロバクター属(特開昭60
−214889)に属する細菌が知られている。DL−
5−置換ヒダントインを効率よく相当する光学活性アミ
ノ酸に変換するには、5−置換ヒダントインのラセミ化
が必要であり、これらの菌では化学的あるいは酵素的に
5−置換ヒダントインのラセミ化が起こっていると考え
られている。[Prior Art] Microorganisms that convert DL-5-substituted hydantoins into the corresponding optically active amino acids include Flavobacterium (Japanese Patent Publication No. 61-12296) and Bacillus (Japanese Patent Publication No. 61-12296).
(Japanese Patent Publication No. 63-24895), Pseudomonas (Special Publication No. 64-71476), Arthrobacter (Japanese Patent Publication No. 60-Sho.
-214889) are known. DL-
Racemization of 5-substituted hydantoin is necessary to efficiently convert 5-substituted hydantoin into the corresponding optically active amino acid, and racemization of 5-substituted hydantoin occurs chemically or enzymatically in these bacteria. It is believed that there are.
【0003】0003
【発明が解決しようとする課題】中性付近のpHでは、
5−置換ヒダントインの化学的ラセミ化は、ほとんど進
行しない。また従来の細菌は、ラセミ化酵素の生産量が
充分ではなかった。[Problem to be solved by the invention] At a pH near neutrality,
Chemical racemization of 5-substituted hydantoins hardly proceeds. Furthermore, conventional bacteria did not produce enough racemization enzymes.
【0004】0004
【課題を解決するための手段】本発明は、このような課
題を解決するために、ラセミ化酵素を持つ細菌から、そ
の遺伝子をクローニングし、遺伝子増幅、転写及び翻訳
活性を高めることにより目的の酵素生産量を高めようと
するものである。すなわち本発明は、5−置換ヒダント
インラセミ化酵素の遺伝子、それを含むDNA断片、そ
のDNA断片を組み込んだベクターDNA、そのベクタ
ーDNAにより形質転換された微生物、該微生物を使用
する5−置換ヒダントインのラセミ化方法、該微生物か
ら調製したラセミ化酵素、及び本ラセミ化酵素による5
−置換ヒダントインのラセミ化方法である。[Means for Solving the Problems] In order to solve the above-mentioned problems, the present invention clones a gene from a bacterium that has a racemization enzyme, and increases gene amplification, transcription, and translation activities to achieve the objective. The aim is to increase enzyme production. That is, the present invention provides a gene for a 5-substituted hydantoin racemase, a DNA fragment containing the gene, a vector DNA incorporating the DNA fragment, a microorganism transformed with the vector DNA, and a 5-substituted hydantoin produced using the microorganism. 5 using a racemization method, a racemization enzyme prepared from the microorganism, and the present racemization enzyme.
- A method for racemizing substituted hydantoins.
【0005】本発明を更に具体的に説明する。The present invention will be explained in more detail.
【0006】本発明でラセミ化される5−置換ヒダント
インは、一般式(I)で示されるものである。
(但し、式中Rは5−置換基を示す)Rの具体例として
は、種々のアミノ酸に対応した5−置換ヒダントインに
対応したものがあり、例えば、β−ラクタム系抗生物質
の側鎖として重要なp−ヒドロキシ−D−フェニルグリ
シン、D−フェニルグリシン、D−システイン、D−ア
スパラギン酸など、アンジオテンシン変換酵素阻害剤の
合成原料としてのD−ホモフェニルアラニン或いは除草
剤であるL−2−アミノ−4−メチルフォスフィノ酪酸
に対応したものがあり、又更に、5−置換ヒダントイン
に対応するアミノ酸としてアラニン・CH3 CH(N
H2)COOH、バリン・(CH3)2 CHCH(N
H2)COOH、ロイシン・(CH3)2 CHCH2
CH(NH2)COOH、イソロイシン・CH3 C
H2 CH(CH3)CH(NH2)COOH、セリン
・HOCH2 CH(NH2)COOH、スレオニン・
CH3 CH(OH)CH(NH2)COOH、メチオ
ニン・CH3 SCH2(NH2)COOH、フェニル
アラニンC6H5CH2 CH(NH2 )COOH、
チロシン・HOC6 H4 CH2 CH( NH2)
COOH 、に対応したものが重要であり、アルキル基
を示すのもとして、メチル基、イソプロピル基、イソブ
チル基、1−メチルプロピル基、又、ヒドロキシル基、
アルキルチオ基、ヒドロキシフェニル基或いはインドリ
ル基等で置換されたアルキル基を示すものとして、ヒド
ロキシメチル基、1−ヒドロキシエチル基、2−メチル
チオエチル基、ベンジル基、p−ヒドロキシベンジル基
或いはインドリルメチル基がある。
(1)遺伝子のクローニング
シュードモナス属NS671菌(FERM P−95
43)は、DL−5−置換ヒダントインを相当するL−
アミノ酸に変換する能力を持つ細菌である。我々は、こ
の細菌から5−置換ヒダントイン変換に関与する遺伝子
、すなわちDL特異的ヒダントイナーゼとL特異的N−
カルバミルアミノ酸ハイドロラーゼの遺伝子をクローニ
ングした(特願平2−137120)。このとき同時に
クローニングされた遺伝子が5−置換ヒダントインラセ
ミ化酵素のものであることが明らかになった。The 5-substituted hydantoin to be racemized in the present invention is represented by general formula (I). (However, in the formula, R represents a 5-substituent group.) Specific examples of R include those corresponding to 5-substituted hydantoins corresponding to various amino acids; for example, as a side chain of β-lactam antibiotics. Important p-hydroxy-D-phenylglycine, D-phenylglycine, D-cysteine, D-aspartic acid, D-homophenylalanine as a synthetic raw material for angiotensin converting enzyme inhibitor, or L-2-amino as a herbicide. There is an amino acid corresponding to -4-methylphosphinobutyric acid, and there is also an amino acid corresponding to 5-substituted hydantoin, such as alanine/CH3CH(N
H2) COOH, valine (CH3)2 CHCH(N
H2) COOH, leucine (CH3)2 CHCH2
CH(NH2)COOH, isoleucine/CH3C
H2 CH(CH3)CH(NH2)COOH, serine・HOCH2 CH(NH2)COOH, threonine・
CH3 CH(OH)CH(NH2)COOH, Methionine CH3 SCH2(NH2)COOH, Phenylalanine C6H5CH2 CH(NH2)COOH,
Tyrosine・HOC6 H4 CH2 CH (NH2)
COOH is important, and examples of alkyl groups include methyl, isopropyl, isobutyl, 1-methylpropyl, hydroxyl,
As an alkyl group substituted with an alkylthio group, hydroxyphenyl group, or indolyl group, hydroxymethyl group, 1-hydroxyethyl group, 2-methylthioethyl group, benzyl group, p-hydroxybenzyl group, or indolylmethyl group There is. (1) Gene cloning Pseudomonas NS671 (FERM P-95
43) converted the DL-5-substituted hydantoin to the corresponding L-
A bacterium that has the ability to convert amino acids into amino acids. We obtained genes involved in 5-substituted hydantoin conversion from this bacterium, namely DL-specific hydantoinase and L-specific N-
The gene for carbamyl amino acid hydrolase was cloned (Japanese Patent Application No. 2-137120). It was revealed that the gene cloned at the same time was that of a 5-substituted hydantoin racemase.
【0006】シュードモナス属NS671菌(FERM
P−9543)のプラスミドpHN671を制限酵
素MboIにより部分消化し、制限酵素BamHI消化
してホスファターゼ処理したプラスミドベクターpUC
18にライゲーションした。この組換え体DNAを用い
て大腸菌JM103を形質転換し、得られた形質転換株
をDL−5−(2−メチルチオエチル)ヒダントインを
唯一の窒素源とする寒天培地にまいた。目的の遺伝子を
含む組換え体DNAを持つ形質転換株は、DL−5−(
2−メチルチオエチル)ヒダントインをL−アミノ酸に
変換する際に生成するアンモニウムイオンを窒素源とし
て利用し、上記の寒天培地で生育し、コロニーを形成す
るので容易に分離できる。この選択培地上に形成された
コロニーから形質転換株を培養し、プラスミドDNAを
調製した結果、約10.2キロ塩基と約15.5キロ塩
基の大きさを持つ2種類のプラスミドが得られた。前者
のプラスミドをpHPB12、後者のプラスミドをpH
PB14と命名した。プラスミドpHPB12は、DL
特異的ヒダントイナーゼの遺伝子(図1、ORF2とO
RF3)とL特異的N−カルバミルアミノ酸ハイドロラ
ーゼの遺伝子(図1、ORF4)を含んでいた(特願平
2−137120)。プラスミドpHPB14は、プラ
スミドpHPB12の挿入DNAの下流が約5.3キロ
塩基だけ伸びた構造になっていることが制限酵素消化に
よるDNA断片の解析から明らかになった。[0006] Pseudomonas NS671 (FERM
Plasmid vector pUC obtained by partially digesting plasmid pHN671 of P-9543) with restriction enzyme MboI, digesting with restriction enzyme BamHI, and treating with phosphatase.
It was ligated to 18. E. coli JM103 was transformed using this recombinant DNA, and the resulting transformant was spread on an agar medium containing DL-5-(2-methylthioethyl)hydantoin as the sole nitrogen source. The transformed strain containing the recombinant DNA containing the gene of interest is DL-5-(
It uses ammonium ions produced when converting 2-methylthioethyl)hydantoin into L-amino acids as a nitrogen source, grows on the above-mentioned agar medium, and forms colonies that can be easily separated. As a result of culturing transformants from colonies formed on this selective medium and preparing plasmid DNA, two types of plasmids with sizes of approximately 10.2 kilobases and approximately 15.5 kilobases were obtained. . The former plasmid is pHPB12, the latter plasmid is pHPB12, and the latter plasmid is pHPB12.
It was named PB14. Plasmid pHPB12 is DL
Specific hydantoinase genes (Fig. 1, ORF2 and O
RF3) and L-specific N-carbamyl amino acid hydrolase gene (Fig. 1, ORF4) (Japanese Patent Application No. 137120/1999). Analysis of DNA fragments obtained by restriction enzyme digestion revealed that plasmid pHPB14 has a structure in which the downstream part of the inserted DNA of plasmid pHPB12 is extended by about 5.3 kilobases.
【0007】(2)プラスミドpHPB14がコードす
る変換能
プラスミドpHPB14で大腸菌JM103を形質転換
し、アンピシリン耐性を指標にして形質転換株を得た。
この形質転換株は、D−5−(2−メチルチオエチル)
ヒダントインを全てL−メチオニンに変換する能力を有
していた。これに対して、プラスミドpHPB12によ
る形質転換株(FERM P−11176)は、D−
5−(2−メチルチオエチル)ヒダントインをN−カル
バミル−D−メチオニンにしか変換できない。(2) Transformability encoded by plasmid pHPB14 Escherichia coli JM103 was transformed with plasmid pHPB14, and a transformed strain was obtained using ampicillin resistance as an indicator. This transformed strain is D-5-(2-methylthioethyl)
It had the ability to convert all hydantoin into L-methionine. On the other hand, the transformed strain (FERM P-11176) using plasmid pHPB12 was D-
5-(2-methylthioethyl)hydantoin can only be converted to N-carbamyl-D-methionine.
【0008】(3)プラスミドpHPB14の縮小プラ
スミドpHPB14の制限酵素地図を図1に示した。実
線部分はベクターDNAであるpUC18を、棒線部分
はシュードモナス属NS671菌(FERMP−954
3)のプラスミドpHN671由来の挿入DNAを示す
。7.5キロ塩基位置の制限酵素BamHI部位よりも
上流の挿入DNAは、プラスミドpHPB12のものと
同一である。制限酵素名に附記した数字は挿入DNAの
始点からの距離(キロ塩基)を示す。塩基配列決定の結
果見いだされたオープンリーディングフレーム(ORF
)の領域と向きを矢印で示した。(3) Reduction of plasmid pHPB14 The restriction enzyme map of plasmid pHPB14 is shown in FIG. The solid line portion represents vector DNA pUC18, and the bar line portion represents Pseudomonas NS671 (FERMP-954).
3) shows the inserted DNA derived from plasmid pHN671. The inserted DNA upstream of the restriction enzyme BamHI site at the 7.5 kilobase position is identical to that of plasmid pHPB12. The number appended to the restriction enzyme name indicates the distance (kilobases) from the starting point of the inserted DNA. Open reading frame (ORF) discovered as a result of base sequencing
) area and direction are indicated by arrows.
【0009】制限酵素SalIで消化したプラスミドp
HPB14を、制限酵素AflII、SnaBI、Sp
lI、SphI、あるいはXhoIでそれぞれ二重消化
し、必要に応じKlenow酵素反応により末端を平滑
化し、セルフライゲーションさせ、欠失プラスミドを得
た。これらの欠失プラスミドで大腸菌JM103を形質
転換し、得られた形質転換株の変換能を調べた。この結
果、プラスミドpHPB14の10.2キロ塩基位置の
制限酵素SnaBI部位よりも下流を欠失させても、D
−5−(2−メチルチオエチル)ヒダントインを全てL
−メチオニンに変換する能力が保持されているが、9.
1キロ塩基位置の制限酵素SplI部位よりも下流を欠
失させると、もはや上記変換能が消失する(D−5−(
2−メチルチオエチル)ヒダントインをN−カルバミル
−D−メチオニンに変換する)ことが分かった。Plasmid p digested with restriction enzyme SalI
HPB14 was treated with restriction enzymes AflII, SnaBI, Sp
This was double digested with lI, SphI, or XhoI, and if necessary, the ends were blunted by Klenow enzyme reaction, followed by self-ligation to obtain a deletion plasmid. E. coli JM103 was transformed with these deletion plasmids, and the conversion ability of the resulting transformants was examined. As a result, even if the region downstream of the restriction enzyme SnaBI site at the 10.2 kilobase position of plasmid pHPB14 was deleted, D
-5-(2-methylthioethyl)hydantoin is all L
- Retains the ability to convert to methionine, but 9.
When the region downstream of the restriction enzyme SplI site at the 1 kilobase position is deleted, the above-mentioned conversion ability is lost (D-5-(
2-methylthioethyl)hydantoin to N-carbamyl-D-methionine).
【0010】(4)塩基配列の決定
プラスミドpHPB14の7.0キロ塩基位置から11
.1キロ塩基位置までの制限酵素EcoRI消化断片を
M13mp18ファージにサブクローニングした。この
サブクローニングされた挿入DNA部分を各種制限酵素
あるいはキロシークエンス用ディリーションキット(宝
酒造)を用いて縮め、ジデオキシ法によって塩基配列を
決定した。プラスミドpHPB14の7.5キロ塩基位
置の制限酵素BamHI部位よりも上流の塩基配列は、
プラスミドpHPB12の挿入DNAの塩基配列と同一
であった。この結果、2個の新しいオープンリーディン
グフレーム、ORF5とORF6が見いだされた(図1
)。(4) Determination of base sequence 11 from 7.0 kilobase position of plasmid pHPB14
.. The restriction enzyme EcoRI digested fragment up to 1 kilobase position was subcloned into M13mp18 phage. This subcloned inserted DNA portion was shortened using various restriction enzymes or a kilosequencing dilation kit (Takara Shuzo), and the base sequence was determined by the dideoxy method. The nucleotide sequence upstream of the restriction enzyme BamHI site at the 7.5 kilobase position of plasmid pHPB14 is as follows:
The base sequence was the same as the inserted DNA of plasmid pHPB12. As a result, two new open reading frames, ORF5 and ORF6, were discovered (Figure 1
).
【0011】(5)欠失プラスミドの作製プラスミドp
HPB14を制限酵素SalIとSnaBIで二重消化
し、Klenow酵素処理後、セルフライゲーションさ
せ、プラスミドpSNA101(ORF2、ORF3、
ORF4、ORF5、及びORF6を含む)を作製した
。プラスミドpSNA101を制限酵素KpnIで消化
し、セルフライゲーションさせ、プラスミドpKPN1
7(ORF6を含む)を作製した。プラスミドpKPN
17を制限酵素EcoRIで消化し、ホスファターゼ処
理し、プラスミドpHPB12の6.4キロ塩基の制限
酵素EcoRI消化断片(ORF2、ORF3、及びO
RF4を含む)とライゲーションさせた。オープンリー
ディングフレームの向きが同じになるようにDNA断片
が挿入されたものを選び、プラスミドpSNAdEE(
ORF2、ORF3、ORF4、及びORF6を含む)
と命名した。プラスミドpSNAdEEで大腸菌JM1
03を形質転換して得られた形質転換株は、D−5−(
2−メチルチオエチル)ヒダントインを全てL−メチオ
ニンに変換する能力を有していた。すなわち、ORF5
は本変換には必要ないことが分かった。したがって、O
RF6が本変換において重要な働きをしていると考えら
れた。(5) Preparation of deletion plasmid Plasmid p
HPB14 was double digested with restriction enzymes SalI and SnaBI, treated with Klenow enzyme, self-ligated, and plasmid pSNA101 (ORF2, ORF3,
(including ORF4, ORF5, and ORF6) were created. Plasmid pSNA101 was digested with the restriction enzyme KpnI and self-ligated to create plasmid pKPN1.
7 (containing ORF6) was produced. Plasmid pKPN
17 was digested with the restriction enzyme EcoRI, treated with phosphatase, and a 6.4-kilobase restriction enzyme EcoRI-digested fragment of plasmid pHPB12 (ORF2, ORF3, and
RF4). Select a DNA fragment into which the open reading frame is oriented in the same direction, and add the plasmid pSNAdEE (
(including ORF2, ORF3, ORF4, and ORF6)
It was named. E. coli JM1 with plasmid pSNAdEE
The transformed strain obtained by transforming D-5-(
It had the ability to convert all 2-methylthioethyl)hydantoin into L-methionine. That is, ORF5
It turns out that is not necessary for this conversion. Therefore, O
It was thought that RF6 plays an important role in this conversion.
【0012】(6)ORF6の機能
プラスミドpKPN17で形質転換された大腸菌JM1
03とプラスミドpHPB12で形質転換された大腸菌
JM103(FERM P−11176)の混合培養
に、D−5−(2−メチルチオエチル)ヒダントインを
添加すると、全てL−メチオニンに変換された。このこ
とはORF6が、ORF2、ORF3、及びORF4と
は別の細胞で発現されても正常に機能することを示して
いる。プラスミドpKPN17で形質転換された大腸菌
JM103の培養に、D−5−(2−メチルチオエチル
)ヒダントインを添加し、一定時間反応させた後、細胞
を濾過により除き、プラスミドpHPB12で形質転換
された大腸菌JM103(FERM P−11176
)を代わりに加えて培養すると、反応時間に応じてL−
メチオニンの生成割合が増え、N−カルバミル−D−メ
チオニンの生成割合が減少し、1:1(モル比)の平衡
に達した。このことはORF6が5−置換ヒダントイン
ラセミ化酵素の遺伝子であることを示している。(6) E. coli JM1 transformed with ORF6 functional plasmid pKPN17
When D-5-(2-methylthioethyl)hydantoin was added to a mixed culture of Escherichia coli JM103 (FERM P-11176) transformed with 03 and plasmid pHPB12, all of the D-5-(2-methylthioethyl)hydantoin was converted to L-methionine. This indicates that ORF6 functions normally even when expressed in cells different from ORF2, ORF3, and ORF4. D-5-(2-methylthioethyl)hydantoin was added to the culture of E. coli JM103 transformed with plasmid pKPN17, and after reacting for a certain period of time, the cells were removed by filtration, and E. coli JM103 transformed with plasmid pHPB12 was cultured. (FERM P-11176
) instead of L-
The production ratio of methionine increased and the production ratio of N-carbamyl-D-methionine decreased, reaching an equilibrium of 1:1 (molar ratio). This indicates that ORF6 is a gene for 5-substituted hydantoin racemase.
【0013】(7)ORF6遺伝子産物(5−置換ヒダ
ントインラセミ化酵素)の分子量
プラスミドpKPN17で大腸菌JM103を形質転換
し形質転換株を得た。本形質転換株は、工業技術院微生
物工業技術研究所(微工研)に微工研条寄第3188号
(FERM BP−3188)として寄託された。こ
の形質転換株を培養して得た菌体を破砕し、可溶性画分
を硫安塩析によって分画し、疎水クロマトグラフィー、
イオン交換クロマトグラフィー、ゲル濾過クロマトグラ
フィーにより5−置換ヒダントインラセミ化酵素を精製
した。精製された酵素のSDS−ポリアクリルアミドゲ
ル電気泳動上での見かけの分子量は31,900であっ
た。ゲル濾過クロマトグラフィーから求められた分子量
は約130,000であった。このことから本ラセミ化
酵素は四量体構造を持っていると推定される。配列表に
ORF6を含むプラスミドpKPN17の挿入DNAの
部分塩基配列を示した。ORF6は196番目塩基のA
TGと202番目塩基のATGの2つの開始コドンで始
まる可能性がある。精製された酵素のN端アミノ酸配列
を分析した結果、MetLysIleLysValIl
eAsnProAsnThrの配列であることが明らか
となった。従って、本遺伝子は、202番目塩基のAT
Gを開始コドンとしていることが分かる。塩基配列から
判明する5−置換ヒダントインラセミ化酵素の分子量は
27,090である。(7) Escherichia coli JM103 was transformed with the molecular weight plasmid pKPN17 of the ORF6 gene product (5-substituted hydantoin racemase) to obtain a transformed strain. This transformed strain was deposited with the Institute of Microbial Technology, Agency of Industrial Science and Technology (FERM BP-3188) as FERM BP-3188. The cells obtained by culturing this transformed strain were disrupted, the soluble fraction was fractionated by ammonium sulfate salting out, hydrophobic chromatography,
The 5-substituted hydantoin racemization enzyme was purified by ion exchange chromatography and gel filtration chromatography. The apparent molecular weight of the purified enzyme on SDS-polyacrylamide gel electrophoresis was 31,900. The molecular weight determined from gel filtration chromatography was approximately 130,000. From this, it is presumed that this racemizing enzyme has a tetrameric structure. The partial base sequence of the inserted DNA of plasmid pKPN17 containing ORF6 is shown in the sequence listing. ORF6 is A at the 196th base
It may begin with two start codons: TG and ATG at base 202. As a result of analyzing the N-terminal amino acid sequence of the purified enzyme, MetLysIleLysValIl
It was revealed that the sequence was eAsnProAsnThr. Therefore, this gene has AT at the 202nd base.
It can be seen that G is used as the start codon. The molecular weight of the 5-substituted hydantoin racemase determined from the base sequence is 27,090.
【0014】(8)5−置換ヒダントインラセミ化酵素
遺伝子の利用法
本発明の遺伝子を含むDNA断片とベクターDNAとの
組換え体DNAを導入した大腸菌などの微生物を培地に
培養し、D−5−置換ヒダントインあるいはL−5−置
換ヒダントインを添加すればラセミ体の5−置換ヒダン
トインが得られる。また該微生物から5−置換ヒダント
インラセミ化酵素を調製して、酵素反応を行っても同様
である。本発明の方法を、5−置換ヒダントインをヒダ
ントイナーゼ反応によって相当するN−カルバミルアミ
ノ酸に変換する方法、及び光学活性N−カルバミルアミ
ノ酸をN−カルバミルアミノ酸ハイドロラーゼ反応によ
って相当する光学活性アミノ酸に変換する方法と組み合
わせて用いれば、原料のDL−5−置換ヒダントインの
全量を効率よく光学活性アミノ酸に変換することができ
る。(8) Method of using the 5-substituted hydantoin racemase gene A microorganism such as Escherichia coli into which the recombinant DNA of the DNA fragment containing the gene of the present invention and the vector DNA has been introduced is cultured in a medium, and D-5 If a -substituted hydantoin or an L-5-substituted hydantoin is added, a racemic 5-substituted hydantoin can be obtained. The same effect can also be obtained by preparing a 5-substituted hydantoin racemizing enzyme from the microorganism and carrying out the enzymatic reaction. The method of the present invention includes a method for converting a 5-substituted hydantoin into a corresponding N-carbamyl amino acid by a hydantoinase reaction, and a method for converting an optically active N-carbamyl amino acid into a corresponding optically active amino acid by an N-carbamyl amino acid hydrolase reaction. When used in combination with a conversion method, the entire amount of DL-5-substituted hydantoin as a raw material can be efficiently converted into an optically active amino acid.
【0015】[0015]
【実施例】実施例1.各種5−置換ヒダントインのラセ
ミ化
プラスミドpKPN17で形質転換された大腸菌JM1
03(FERM BP−3188)を50mlのLB
培地に植菌し、600nmのODが約0.2になるまで
30℃で振盪培養した。250μlの200mM I
PTGを添加し、さらに30℃で2時間振盪培養した。
この培養の20OD(600nm)分を遠心し、菌体を
得た。これを0.2%のD体あるいはL体の各種5−置
換ヒダントインを含む10mlの20mM トリス塩
酸バッファー(pH7.5)、0.1M塩化ナトリウム
に懸濁し、30℃で振盪させた。一定時間後に、1ml
ずつ抜き取り、遠心と濾過によって菌体を除き上清を得
た。[Example] Example 1. E. coli JM1 transformed with racemized plasmid pKPN17 of various 5-substituted hydantoins
03 (FERM BP-3188) in 50ml LB
The cells were inoculated into a medium and cultured with shaking at 30°C until the OD at 600 nm reached approximately 0.2. 250μl of 200mM I
PTG was added and cultured with shaking at 30°C for 2 hours. A portion of 20 OD (600 nm) of this culture was centrifuged to obtain bacterial cells. This was suspended in 10 ml of 20 mM Tris-HCl buffer (pH 7.5) and 0.1 M sodium chloride containing 0.2% of D- or L-form various 5-substituted hydantoins, and shaken at 30°C. After a certain period of time, 1ml
The cells were removed by centrifugation and filtration to obtain a supernatant.
【0016】この上清に存在する5−置換ヒダントイン
のD体とL体の割合を光学異性体分離用カラムCHIR
ALPAK WH(ダイセル化学工業)を用いてHP
LCによって分析し、結果を表1に示した。対照として
、プラスミドpUC18で形質転換された大腸菌JM1
03を用いて上記と同様の操作を行った結果、D体また
はL体の5−置換ヒダントインからの、それぞれL体ま
たはD体の5−置換ヒダントインの生成は検出できなか
った。[0016] The ratio of D-form and L-form of 5-substituted hydantoin present in this supernatant was measured using CHIR, a column for optical isomer separation.
HP using ALPAK WH (Daicel Chemical Industries)
It was analyzed by LC and the results are shown in Table 1. As a control, E. coli JM1 transformed with plasmid pUC18
As a result of performing the same operation as above using 03, the production of L-form or D-form 5-substituted hydantoin from D-form or L-form 5-substituted hydantoin, respectively, could not be detected.
【0017】[0017]
【0018】実施例2.ラセミ化酵素の精製プラスミド
pKPN17で形質転換された大腸菌JM103(FE
RM BP−3188)を50mlのLB培地に植菌
し、30℃で一晩前培養した。この全量を3Lの培地(
6g/L リン酸二ナトリウム、3g/L リン酸
一カリウム、0.5g/L 塩化ナトリウム、1g/
L 塩化アンモニウム、5mM 硫酸マグネシウム
、0.5mM 塩化カルシウム、1% グリセロー
ル、2% 酵母エキス)に加え、ジャーファーメンタ
ーで550nmのODが約10になるまで30℃で培養
した。これに15mlの200mM IPTGを添加
し、さらに約2時間半培養した後、遠心によって集菌し
、約100gの湿菌体を得た。Example 2. Purification of racemization enzyme E. coli JM103 (FE) transformed with plasmid pKPN17
RM BP-3188) was inoculated into 50 ml of LB medium and precultured at 30°C overnight. Transfer this entire volume to 3L of medium (
6g/L disodium phosphate, 3g/L monopotassium phosphate, 0.5g/L sodium chloride, 1g/L
L ammonium chloride, 5mM magnesium sulfate, 0.5mM calcium chloride, 1% glycerol, 2% yeast extract) and cultured at 30°C in a jar fermenter until the OD at 550nm reached about 10. After adding 15 ml of 200 mM IPTG to this and further culturing for about two and a half hours, the cells were collected by centrifugation to obtain about 100 g of wet bacterial cells.
【0019】上記湿菌体を500mlの20mM ト
リス塩酸バッファー(pH7.5)、0.1M 塩化
ナトリウムに懸濁し、ゴーリンホモジェナイザーによっ
て菌体を破砕した。これを遠心にかけ不溶物を除き、上
清を得た。この上清の60−90%飽和硫安塩析画分を
100mlの20mM トリス塩酸バッファー(pH
7.5)、0.1M 塩化ナトリウム、0.5M
硫安に溶解し、同じバッファーで平衡化したブチル−ト
ヨパール(TOSOH)の疎水クロマトグラフィーにか
けた。The wet bacterial cells were suspended in 500 ml of 20 mM Tris-HCl buffer (pH 7.5) and 0.1 M sodium chloride, and the cells were disrupted using a Gorlin homogenizer. This was centrifuged to remove insoluble matter to obtain a supernatant. The 60-90% saturated ammonium sulfate salting out fraction of this supernatant was added to 100 ml of 20 mM Tris-HCl buffer (pH
7.5), 0.1M sodium chloride, 0.5M
It was subjected to hydrophobic chromatography on butyl-Toyopearl (TOSOH) dissolved in ammonium sulfate and equilibrated with the same buffer.
【0020】ラセミ化酵素の活性は次のようにして検出
した。すなわち、1mlのLB培地にプラスミドpHP
B12で形質転換された大腸菌JM103を植菌し、こ
れに100μlの2% D−5−(2−メチルチオエ
チル)ヒダントイン、5μlの200mM IPTG
、そして1μlの被検液を加え、30℃で一晩振盪培養
した。培養液をTLCにより分析し、メチオニン(L体
)またはN−カルバミルメチオニン(D体)の生成を調
べた。メチオニン(L体)の生成はラセミ化酵素活性の
存在を示している。また、ラセミ化酵素活性がないとき
はN−カルバミルメチオニン(D体)のみが生成する。The activity of racemization enzyme was detected as follows. That is, plasmid pHP was added to 1 ml of LB medium.
E. coli JM103 transformed with B12 was inoculated with 100 μl of 2% D-5-(2-methylthioethyl)hydantoin and 5 μl of 200 mM IPTG.
Then, 1 μl of the test solution was added, and cultured with shaking at 30° C. overnight. The culture solution was analyzed by TLC to examine the production of methionine (L-form) or N-carbamylmethionine (D-form). The production of methionine (L-form) indicates the presence of racemization enzyme activity. Moreover, when there is no racemization enzyme activity, only N-carbamylmethionine (D form) is produced.
【0021】ブチル−トヨパールクロマトグラフィーか
ら得られたラセミ化酵素活性画分を20mM トリス
塩酸バッファー(pH7.5)、50mM 塩化ナト
リウムに対して透析し、同じバッファーで平衡化したD
EAE−セファセル(ファルマシア)のイオン交換クロ
マトグラフィーにかけた。ラセミ化酵素活性は100−
150mM程度の塩化ナトリウムで溶出された。D
It was subjected to ion exchange chromatography on EAE-Sephacel (Pharmacia). Racemization enzyme activity is 100-
It was eluted at about 150mM sodium chloride.
【0022】DEAE−セファセルクロマトグラフィー
から得られたラセミ化酵素活性画分をPM10メンブレ
ン(アミコン)によって濃縮し、20mM トリス塩
酸バッファー(pH7.5)、0.1M 塩化ナトリ
ウムで平衡化したセファディックスG−200スーパー
ファインのゲル濾過クロマトグラフィーにかけた。この
結果、ラセミ化酵素活性は分子量約130,000の位
置に溶出された。このラセミ化酵素活性画分をSDS−
ポリアクリルアミドゲル電気泳動によって分析した結果
、分子量31,900の位置にバンドが現れた。したが
って、本ラセミ化酵素は四量体構造を持っていると推定
される。The racemization enzyme active fraction obtained from DEAE-Sephacel chromatography was concentrated using a PM10 membrane (Amicon), and Sephadic was equilibrated with 20mM Tris-HCl buffer (pH 7.5) and 0.1M sodium chloride. It was subjected to gel filtration chromatography using G-200 Superfine. As a result, racemization enzyme activity was eluted at a molecular weight of approximately 130,000. This racemization enzyme active fraction was collected using SDS-
As a result of analysis by polyacrylamide gel electrophoresis, a band appeared at a molecular weight of 31,900. Therefore, this racemizing enzyme is presumed to have a tetrameric structure.
【0023】[0023]
【発明の効果】本発明によって、5−置換ヒダントイン
ラセミ化酵素の遺伝子を大腸菌などの微生物で安定に高
度に発現させることが可能になった。この結果、このよ
うな微生物から容易に本酵素を調製できるようになった
。According to the present invention, it has become possible to stably and highly express the gene for 5-substituted hydantoin racemase in microorganisms such as Escherichia coli. As a result, the present enzyme can now be easily prepared from such microorganisms.
【0024】[0024]
【配列表】配列の長さ:1282
配列の型:核酸
鎖の数:二本鎖
トポロジー:直鎖状
配列の種類:他の核酸 Plasmid DNA起
源生物名:シュードモナス(Pseudomonas
sp.)
株名:NS671
配列の特徴
特徴を表す記号:CDS
存在位置:202..951
特徴を決定した方法:E
配列
GAATTCGAGC TCGGTACCTG AAA
TTGATGG TGTAGTAGTG ATTGAT
AGTT TATAGAAACA 60ATTGT
TGACC CTTGGAAAAA ACAAGCAA
AC TAAAAACTTA TAAATCTCCT
GAAAAGAAAG 120AATATTGCGG
GAAATTAAGA AATTTGGGTC CG
TGGAAAAA GCTATAAAAT AAATT
CACTA 180AATTCTAGGA GGAA
A ATG GTT ATG AAA ATT AAA
GTT ATC AAC CCG AAT ACA
231
Met Lys Ile Lys Val
Ile Asn Pro Asn Thr
1
5
10ACT TTG GCA ATG A
CA AAG GGA ATT GAA CAT GC
T GCT AAG TCA GCT GCA
279Thr Leu Ala Met Thr Ly
s Gly Ile Glu His Ala Ala
Lys Ser Ala Ala
15
20 2
5 AGA TCT GAT ACT CAA ATT
GTT GCA GTG AGT CCT AAA
ATG GGT CCG GCT 327Arg
Ser Asp Thr Gln Ile Val
Ala Val Ser Pro Lys Met G
ly Pro Ala
30 35
40 TCA AT
T GAA TCC TAC TAT GAT GAA
TAT TTA AGC ATT CCA GGA
GTA ATT 375Ser Ile Glu
Ser Tyr Tyr Asp Glu Tyr
Leu Ser Ile Pro Gly Val I
le 45
50
55 GAG GAA
ATT AAA AAG GGA GAA GAA G
AA GGA GTA GAT GCA TTT GT
T ATA 423Glu Glu Ile L
ys Lys Gly Glu Glu Glu Gl
y Val Asp Ala Phe Val Ile
60
65 70
GCA TGC TGG GG
A GAC CCT GGA TTG CAT GCT
GCG AGA GAA GTA ACA GAT
471Ala Cys Trp Gly Asp
Pro Gly Leu His Ala Ala
Arg Glu Val Thr Asp 75
80
85
90 AAA CCA GTT GTA
GGC ATT GCG GAA TCC TCC G
TT TAT TTA GCA TCA ATG
519Lys Pro Val Val Gly I
le Ala Glu Ser Ser Val Ty
r Leu Ala Ser Met
95
100 1
05 CTT GCA GCC AGA TTT TC
C GTG GTC ACA GTT TTA CCT
AGA ATT AAA ACA 567Le
u Ala Ala Arg Phe Ser Val
Val Thr Val Leu Pro Arg
Ile Lys Thr 1
10 115
120 A
TG TTA GAA GAC CTG GTT GA
T TCA TAC GGT ATG CAA AAA
CGT GTA CTA 615Met Le
u Glu Asp Leu Val Asp Ser
Tyr Gly Met Gln Lys Arg
Val Leu 125
130
135 AAC
ATC CGT ACG ACA CCG ATG
GGC GTA TTA GAT TTT GAG A
GA GAT CCA 663Asn Ile
Arg Thr Thr Pro Met Gly V
al Leu Asp Phe Glu Arg As
p Pro 140
145
150 GAA GCG G
GA ATT GAA ATG TTA AGG CA
G GAA GGG AAA AGA GCG GTA
GAG 711Glu Ala Gly Il
e Glu Met Leu Arg Gln Glu
Gly Lys Arg Ala Val Glu
155 160
165
170 GAA GAT AAT
GCA GAA GCT ATT TTA CTT
GGA TGT GCT GGT ATG GCA G
AA 759Glu Asp Asn Ala
Glu Ala Ile Leu Leu Gly C
ys Ala Gly Met Ala Glu
175
180
185
TTT GCG GAT AGC CTT GAA A
AA GAA TTA GGA GTT CCC GT
T ATC GAT GGA 807Phe A
la Asp Ser Leu Glu Lys Gl
u Leu Gly Val Pro Val Ile
Asp Gly 190
195
200 GTT GTA GC
G GGT GTG AAA TTC GCC GAA
ACA ATT GTT GAT CTA GGA
AAG 855Val Val Ala Gly
Val Lys Phe Ala Glu Thr
Ile Val Asp Leu Gly Lys
205
210 215
AAA ACA AGT
AAA CTA AAA ACT TAT AAA T
AT CCA GAG AAA AAA GAA TA
T 903Lys Thr Ser Lys L
eu Lys Thr Tyr Lys Tyr Pr
o Glu Lys Lys Glu Tyr
220 225
230
GTT GGG GCA TTG GA
G AAC TTT GGA CGG AAT CAA
ACA ACA ACA AAA TAA 9
51Val Gly Ala Leu Glu Asn
Phe Gly Arg Asn Gln Thr
Thr Thr Lys 235
240
245 AAAATTA
AAG AGTTTTCACA CTTGTTAAAT
CATAGATAGT TTATATCAAT TT
TATTTAAT 1011TTTGGGCGAA T
TTCAATTAC TAGTGAAATT GCCC
ATTTTT TAAAAGCATA ACAGGGA
TTT 1071CAGTGATATT GACTGT
TAGG CAGAACAGAA ATTTTATTA
T ACATCCCTTG AATGAATTAT 1
131TGCATAGCAA ATGGGTGAAC
TATAAAAGTT CTTACATCAA TAT
GTATCAA AAAGGAGTGC 1191AG
TTATTCAT GGATTTAAAA TCTAA
CAGCG TCATCAATCC AGATCCAA
AT AGGATTCAAA 1251CAAATAA
TTT TAACATCATA AAAACAAGCT
T
1282[Sequence list] Sequence length: 1282 Sequence type: Number of nucleic acid strands: Double stranded Topology: Linear Sequence type: Other nucleic acids Plasmid DNA source organism name: Pseudomonas
sp. ) Strain name: NS671 Sequence characteristics Symbol representing characteristics: CDS Location: 202. .. 951 How the characteristics were determined: E Sequence GAATTCGAGC TCGGTACCTG AAA
TTGATGG TGTAGTAGTG ATTGAT
AGTT TATAGAAACA 60ATTGT
TGACC CTTGGAAAAAAA
AC TAAAAACTTA TAAATCTCCT
GAAAAGAAAG 120AATATTGCGG
GAAATTAAGA AATTTGGGTC CG
TGGAAAAAAGCTATAAAATAAATT
CACTA 180AATTCTAGGA GGAA
A ATG GTT ATG AAA ATT AAA
GTT ATC AAC CCG AAT ACA
231
Met Lys Ile Lys Val
Ile Asn Pro Asn Thr
1
5
10ACT TTG GCA ATG A
CA AAG GGA ATT GAA CAT GC
T GCT AAG TCA GCT GCA
279Thr Leu Ala Met Thr Ly
s Gly Ile Glu His Ala Ala
Lys Ser Ala Ala
15
20 2
5 AGA TCT GAT ACT CAA ATT
GTT GCA GTG AGT CCT AAA
ATG GGT CCG GCT 327Arg
Ser Asp Thr Gln Ile Val
Ala Val Ser Pro Lys Met G
ly Pro Ala
30 35
40 TCA AT
T GAA TCC TAC TAT GAT GAA
TAT TTA AGC ATT CCA GGA
GTA ATT 375Ser Ile Glu
Ser Tyr Tyr Asp Glu Tyr
Leu Ser Ile Pro Gly Val I
le 45
50
55 GAG GAA
ATT AAA AAG GGA GAA GAA G
AA GGA GTA GAT GCA TTT GT
T ATA 423 Glu Glu Ile L
ys Lys Gly Glu Glu Glu Gl
y Val Asp Ala Phe Val Ile
60
65 70
GCA TGC TGG GG
A GAC CCT GGA TTG CAT GCT
GCG AGA GAA GTA ACA GAT
471Ala Cys Trp Gly Asp
Pro Gly Leu His Ala Ala
Arg Glu Val Thr Asp 75
80
85
90 AAA CCA GTT GTA
GGC ATT GCG GAA TCC TCC G
TT TAT TTA GCA TCA ATG
519Lys Pro Val Val Gly I
le Ala Glu Ser Ser Val Ty
r Leu Ala Ser Met
95
100 1
05 CTT GCA GCC AGA TTT TC
C GTG GTC ACA GTT TTA CCT
AGA ATT AAA ACA 567Le
u Ala Ala Arg Phe Ser Val
Val Thr Val Leu Pro Arg
Ile Lys Thr 1
10 115
120A
TG TTA GAA GAC CTG GTT GA
T TCA TAC GGT ATG CAA AAA
CGT GTA CTA 615Met Le
u Glu Asp Leu Val Asp Ser
Tyr Gly Met Gln Lys Arg
Val Leu 125
130
135 AAC
ATC CGT ACG ACA CCG ATG
GGC GTA TTA GAT TTT GAG A
GA GAT CCA 663 Asn Ile
Arg Thr Thr Pro Met Gly V
al Leu Asp Phe Glu Arg As
p Pro 140
145
150 GAA GCG G
GA ATT GAA ATG TTA AGG CA
G GAA GGG AAA AGA GCG GTA
GAG 711Glu Ala Gly Il
e Glu Met Leu Arg Gln Glu
Gly Lys Arg Ala Val Glu
155 160
165
170 GAA GAT AAT
GCA GAA GCT ATT TTA CTT
GGA TGT GCT GGT ATG GCA G
AA 759Glu Asp Asn Ala
Glu Ala Ile Leu Leu Gly C
ys Ala Gly Met Ala Glu
175
180
185 TTT GCG GAT AGC CTT GAA A
AA GAA TTA GGA GTT CCC GT
T ATC GAT GGA 807Phe A
la Asp Ser Leu Glu Lys Gl
u Leu Gly Val Pro Val Ile
Asp Gly 190
195
200 GTT GTA GC
G GGT GTG AAA TTC GCC GAA
ACA ATT GTT GAT CTA GGA
AAG 855 Val Val Ala Gly
Val Lys Phe Ala Glu Thr
Ile Val Asp Leu Gly Lys
205
210 215
AAA ACA AGT
AAA CTA AAA ACT TAT AAA T
AT CCA GAG AAA AAA GAA TA
T 903Lys Thr Ser Lys L
eu Lys Thr Tyr Lys Tyr Pr
o Glu Lys Lys Glu Tyr
220 225
230
GTT GGG GCA TTG GA
G AAC TTT GGA CGG AAT CAA
ACA ACA ACA AAA TAA 9
51Val Gly Ala Leu Glu Asn
Phe Gly Arg Asn Gln Thr
Thr Thr Lys 235
240
245 AAAATTA
AAG AGTTTTTCACA CTTGTTAAAT
CATAGATAGT TTATATCAAT TT
TATTTAAT 1011TTTGGGCGAA T
TTCAAATTAC TAGTGAAATT GCCC
ATTTTT TAAAAGCATA ACAGGGA
TTT 1071CAGTGATATT GACTGT
TAGG CAGAACAGAA ATTTTATTA
T ACATCCCTTG AATGAATTAT 1
131TGCATAGCAA ATGGGTGAAC
TATAAAAGTT CTTACATCAA TAT
GTATCAA AAAGGAGGTGC 1191AG
TTATTCAT GGATTTAAAA TCTAA
CAGCG TCATCAATCC AGATCCAA
AT AGGATTCAAA 1251CAAATAA
TTT TAACATCATA AAAACAAGCT
T
1282
【図1】図1はプラスミドpHPB14の制限酵素地図
である。FIG. 1 is a restriction enzyme map of plasmid pHPB14.
Claims (2)
から第951番目塩基までの配列を有することを特徴と
する5−置換ヒダントインラセミ化酵素遺伝子。1. A 5-substituted hydantoin racemase gene, which has a sequence from the 202nd base to the 951st base described in the sequence listing.
から第249番目アミノ酸までの配列を有することを特
徴とする5−置換ヒダントインラセミ化酵素。2. A 5-substituted hydantoin racemase having a sequence from the 1st amino acid to the 249th amino acid listed in the sequence listing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3065591A JPH04271784A (en) | 1990-12-10 | 1991-03-06 | 5-substituted hydantoin racemase and gene capable of coding the same |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP40973890 | 1990-12-10 | ||
JP2-409738 | 1990-12-10 | ||
JP3065591A JPH04271784A (en) | 1990-12-10 | 1991-03-06 | 5-substituted hydantoin racemase and gene capable of coding the same |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04271784A true JPH04271784A (en) | 1992-09-28 |
Family
ID=26406729
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3065591A Pending JPH04271784A (en) | 1990-12-10 | 1991-03-06 | 5-substituted hydantoin racemase and gene capable of coding the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04271784A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002072841A1 (en) * | 2001-03-08 | 2002-09-19 | Ajinomoto Co., Inc. | Dna encoding hydantoinase, dna encoding n-carbamyl-l-amino acid hydrolase, recombinant dna, transformed cells, process for producing protein and process for producing optically active amino acid |
WO2006080409A1 (en) * | 2005-01-31 | 2006-08-03 | Kaneka Corporation | 5-substituted hydantoin racemase, dna encoding the same, recombinant dna, transformed cell, and process for production of optically active n-carbamylamino acid or optically active amino acid |
US7713724B2 (en) | 2002-05-23 | 2010-05-11 | Dsm Ip Assets B.V. | Hydantoin racemase |
WO2011003702A1 (en) | 2009-07-09 | 2011-01-13 | Dsm Ip Assets B.V. | Stabilized enzyme compositions |
-
1991
- 1991-03-06 JP JP3065591A patent/JPH04271784A/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002072841A1 (en) * | 2001-03-08 | 2002-09-19 | Ajinomoto Co., Inc. | Dna encoding hydantoinase, dna encoding n-carbamyl-l-amino acid hydrolase, recombinant dna, transformed cells, process for producing protein and process for producing optically active amino acid |
US7098020B2 (en) | 2001-03-08 | 2006-08-29 | Ajinomoto Co., Inc. | DNA encoding hydantoinase, DNA encoding N-carbamyl-L-amino acid hydrolase, recombinant DNA, transformed cell, method of producing protein, and method of producing optically active amino acid |
US7361490B2 (en) | 2001-03-08 | 2008-04-22 | Ajinomoto Co., Inc. | DNA encoding hydantoinase, DNA encoding N-carbamyl-L-amino acid hydrolase, recombinant DNA, transformed cell, method of producing protein and method of producing optically active amino acid |
US8460902B1 (en) | 2001-03-08 | 2013-06-11 | Ajinomoto Co., Inc. | DNA encoding hydantoinase, DNA encoding N-carbamyl-L-amino acid hydrolase, recombinant DNA, transformed cell, method of producing protein, and method of producing optically active amino acid |
US7713724B2 (en) | 2002-05-23 | 2010-05-11 | Dsm Ip Assets B.V. | Hydantoin racemase |
WO2006080409A1 (en) * | 2005-01-31 | 2006-08-03 | Kaneka Corporation | 5-substituted hydantoin racemase, dna encoding the same, recombinant dna, transformed cell, and process for production of optically active n-carbamylamino acid or optically active amino acid |
US7709235B2 (en) | 2005-01-31 | 2010-05-04 | Kaneka Corporation | 5-Substituted hydantoin racemase, DNA encoding the same, recombinant DNA, transformed cell, and process for production of optically active N-carbamylamino acid or optically active amino acid |
JP5096911B2 (en) * | 2005-01-31 | 2012-12-12 | 株式会社カネカ | 5-substituted hydantoin racemase, DNA encoding the same, recombinant DNA, transformed cell, and method for producing optically active N-carbamyl amino acid or optically active amino acid |
WO2011003702A1 (en) | 2009-07-09 | 2011-01-13 | Dsm Ip Assets B.V. | Stabilized enzyme compositions |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8460902B1 (en) | DNA encoding hydantoinase, DNA encoding N-carbamyl-L-amino acid hydrolase, recombinant DNA, transformed cell, method of producing protein, and method of producing optically active amino acid | |
Watabe et al. | Identification and sequencing of a gene encoding a hydantoin racemase from the native plasmid of Pseudomonas sp. strain NS671 | |
US5766918A (en) | Enantioselective amidases and uses thereof | |
Clemente-Jiménez et al. | Optically pure α-amino acids production by the “Hydantoinase Process” | |
EP0662134A1 (en) | Polypeptides involved in streptogramin biosynthesis, nucleotide sequences coding for said polypeptides and use thereof | |
US5807710A (en) | Nucleic acids encoding stable mutants of D-N-α-carbamoylase | |
EP1188826B1 (en) | 5-substituted hydantoin racemase, DNA coding for the same, and process for producing optically active amino acids | |
JPH04271784A (en) | 5-substituted hydantoin racemase and gene capable of coding the same | |
EP1197563B1 (en) | Method for Producing Amino Acids | |
DE69535398T2 (en) | METHOD FOR PRODUCING A D-N-CARBAMOYL-ALPHA AMINO ACID | |
JPH0851992A (en) | Preparation of d-alpha.-amino acid | |
EP1070132B1 (en) | Recombinant l-n-carbamoylase derived from arthrobacter aurescens, and a method for producing l-amino acids by using the same | |
JP4516712B2 (en) | Biological production method of L-pipecolic acid | |
JP4880859B2 (en) | Novel carbonyl reductase, its gene, and its use | |
FR2669643A1 (en) | PROCESS FOR THE ENZYMATIC SYNTHESIS OF AMMONIUM ADIPATE | |
JPH03187398A (en) | One process cephalosporin c amidase enzyme, gene for coding same and its expression in an appropriate host | |
JP4116798B2 (en) | Novel amidase and gene encoding the same | |
CN1989246B (en) | L-amino acid amide asymmetric hydrolase and DNA encoding the same | |
JP2902112B2 (en) | Method for producing D-α-amino acid | |
EP1130108A1 (en) | Methods for racemizing N-acylamino acids and producing optically active amino acids | |
US5824522A (en) | Recombinant decarbamylases for producing D-α-amino acids | |
JP4485734B2 (en) | 5-substituted hydantoin racemase, DNA encoding the same, recombinant DNA, transformed cell, and method for producing optically active amino acid | |
Heras-Vazquez et al. | Optically pure α-amino acids production by the “Hydantoinase Process” | |
JP4561021B2 (en) | 5-substituted hydantoin racemase, DNA encoding the same, recombinant DNA, transformed cell, and method for producing optically active amino acid | |
JP4652915B2 (en) | DNA involved in hydrolysis of norbornane derivatives |